This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bray, F. Articles by Parkin, D. M. Search for Related Content PubMed PubMed Citation Articles by Bray, F. Articles by Parkin, D. M.

Trends in Cervical Squamous Cell Carcinoma Incidence in 13 European Countries: Changing Risk and the Effects of Screening

¹ International Agency for Research Cancer, Lyon, France; ² London School of Hygiene and Tropical Medicine, London, United Kingdom; ³ Queen's University, Belfast, Northern Ireland, United Kingdom; ⁴ Finnish Cancer Registry, Helsinki, Finland; ⁵ Cancer Registry of Norway, Oslo, Norway; ⁶ Karolinska Institutet, Stockholm, Sweden; ⁷ Scientific Institute of Public Health, Brussels, Belgium; ⁸ Thames Cancer Registry, King's College, London, United Kingdom; and ⁹ University of Tampere, Tampere, Finland

Requests for reprints: Freddie Bray, Descriptive Epidemiology Group, IARC, 150 cours Albert-Thomas, 69372 Lyon cedex 08, France. Phone: 33-4-72-73-83-75; Fax: 33-4-72-73-86-50. E-mail: bray{at}iarc.fr

Despite there being sufficient evidence for the effectiveness of screening by cytology in preventing cancer of the cervix uteri, screening policies vary widely among European countries, and incidence is increasing in younger women. This study analyzes trends in squamous cell carcinoma (SCC) of the cervix uteri in 13 European countries to evaluate effectiveness of screening against a background of changing risk. Age-period-cohort models were fitted and period and cohort effects were estimated; these were considered as primarily indicative of screening interventions and changing etiology, respectively. A unique set of estimates was derived by fixing age slopes to one of several plausible age curves under the assumption that the relation between age and cervical cancer incidence is biologically determined. There were period-specific declines in cervical SCC in several countries, with the largest decreases seen in northern Europe. A pattern emerged across Europe of escalating risk in successive generations born after 1930. In the western European countries, a decrease followed by a stabilization of risk by cohort was accompanied by period-specific declines. In southern Europe, stable period, but increasing cohort trends, were observed. Substantial changes have occurred in cervical SCC incidence in Europe and well-organized screening programs have been highly effective in reducing the incidence of cervical SCC. Screening and changing sexual mores largely explain the changing period- and cohort-specific patterns, respectively. The increasing risk in recent cohorts is of obvious concern particularly in countries where no screening programs are in place. Further investigation of the effectiveness of opportunistic screening is warranted as is the observation of differing risk patterns in young cohorts in countries with relatively similar societal structures.

This article has been cited by other articles:

				A. Gauthier, V. Martin-Escudero, L. Moore, N. Ferko, S. de Sanjose, I. Perez-Escolano, F. Catala-Lopez, E. Ferrer, and F. X. Bosch Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain Eur J Public Health, December 1, 2008; 18(6): 674 - 680. [Abstract] [Full Text] [PDF]

				J. Dillner, M. Rebolj, P. Birembaut, K.-U. Petry, A. Szarewski, C. Munk, S. de Sanjose, P. Naucler, B. Lloveras, S. Kjaer, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study BMJ, October 13, 2008; 337(oct13_1): a1754 - a1754. [Abstract] [Full Text] [PDF]

				E. Lazcano-Ponce, L. S. Palacio-Mejia, B. Allen-Leigh, E. Yunes-Diaz, P. Alonso, R. Schiavon, and M. Hernandez-Avila Decreasing Cervical Cancer Mortality in Mexico: Effect of Papanicolaou Coverage, Birthrate, and the Importance of Diagnostic Validity of Cytology Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2808 - 2817. [Abstract] [Full Text] [PDF]

				B. Andrae, L. Kemetli, P. Sparen, L. Silfverdal, B. Strander, W. Ryd, J. Dillner, and S. Tornberg Screening-Preventable Cervical Cancer Risks: Evidence From a Nationwide Audit in Sweden J Natl Cancer Inst, May 7, 2008; 100(9): 622 - 629. [Abstract] [Full Text] [PDF]

				A. S. Gunnell, N. Ylitalo, S. Sandin, P. Sparen, H.-O. Adami, and S. Ripatti A Longitudinal Swedish Study on Screening for Squamous Cell Carcinoma and Adenocarcinoma: Evidence of Effectiveness and Overtreatment Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2641 - 2648. [Abstract] [Full Text] [PDF]

				M. Arbyn, A. O. Raifu, P. Autier, and J. Ferlay Burden of cervical cancer in Europe: estimates for 2004 Ann. Onc., October 1, 2007; 18(10): 1708 - 1715. [Abstract] [Full Text] [PDF]

				K. Aklimunnessa, M. Mori, M. M. H. Khan, F. Sakauchi, T. Kubo, Y. Fujino, S. Suzuki, S. Tokudome, A. Tamakoshi, and for the JACC Study Group Effectiveness of Cervical Cancer Screening Over Cervical Cancer Mortality Among Japanese Women Jpn. J. Clin. Oncol., August 1, 2006; 36(8): 511 - 518. [Abstract] [Full Text] [PDF]

				E. J. Dasbach, E. H. Elbasha, and R. P. Insinga Mathematical Models for Predicting the Epidemiologic and Economic Impact of Vaccination against Human Papillomavirus Infection and Disease Epidemiol. Rev., August 1, 2006; 28(1): 88 - 100. [Abstract] [Full Text] [PDF]

				A. Hildesheim and A. B. de Gonzalez Etiology and prevention of cervical adenocarcinomas. J Natl Cancer Inst, March 1, 2006; 98(5): 292 - 293. [Full Text] [PDF]

				F. Bray, B. Carstensen, H. Moller, M. Zappa, M. P. Zakelj, G. Lawrence, M. Hakama, and E. Weiderpass Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2191 - 2199. [Abstract] [Full Text] [PDF]